Applied Clinical Trials Magazine

??Our October issue is LIVE?? New Trends and Tactics in Outsourcing??Achieving Optimal Adoption of RBQM??The Evolution of Real-World Evidence??and so much more right here?? https://lnkd.in/ecebCNQt

A New Approach to Global Participant Payments Tune in to this live webinar with IQVIA as Zahiah Gueddar digs into the details of paying participants in several notoriously challenging countries, the best practices to navigate these country-specific challenges and introduce a new approach to managing participant payments. Register now: https://lnkd.in/efBSvsAv

?? In this part of his video interview with Applied Clinical Trials Magazine editor Andy Studna, Silvio Galea, chief data & analytics officer, WCG, discusses how sponsors can ensure that patients are properly reporting data.

Industry leaders share their perspectives on the guidance and how it will affect sponsors moving forward.

?? In this video interview with ACT editor Andy Studna, Silvio Galea, chief data & analytics officer, WCG, touches on the usability of clinical technology

Check out our featured virtual events, including live webcasts, panel discussions, and on-demand webinars from Applied Clinical Trials?! #eCOA #Biostatistics #Patient

The combination of Opdivo (nivolumab) plus chemotherapy significantly improved progression-free survival compared to Adcetris (brentuximab vedotin) plus chemotherapy in patients with advanced stage Hodgkin lymphoma, based on findings from the Phase III S1826 trial.

Ashley C Moultrie, CCRP, Senior Director, DEI & Community Engagement, Javara, discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more. Listen to the podcast: https://ow.ly/wInQ50TNSQa

In Part 2 of his Applied Clinical Trials Magazine interview, Stephen Pyke discusses areas where we’ll likely see major advancements in our industry due to #AI, namely speed, quality and productivity in clinical research. Watch the full video here:

Along with my colleagues Adam Kinsey, Gerri Anselmo-Gallagher, and Samir Shah I drew together some thoughts on the Strategic Emergence of Site Networks in clinical research. You can read the full article here at Applied Clinical Trials Magazine: https://lnkd.in/e_Ai9PRY There's no question that the site landscape is moving, and we thought it important to try to set out a framework for how to understand and navigate it what is happening, and why. As I've written before, I see site consolidation as not just a trend but a strategic necessity, helping sites tackle operational pressures and financial challenges. While many industry leaders are embracing site networks, I recognize that smaller organizations often worry about risks, complexity, and costs. It's essential for sponsors to find a balance between operational efficiency and localized expertise. I believe that continued consolidation, along with strategic partnerships and risk-sharing models, will shape what happens next. Special thanks to Lesly Atlas, Pam Sobotka, Anne Lawrence, Sean Jensen, and Gloriana Ordó?ez Carboni for their important contributions. Thoughts, reactions, comments are always welcome.